Skip to main content

Table 5 Detailed results of EQ-5D analysis based on a mixed linear model

From: Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial

Effect Group Month Estimate Standard error p -value
Intercept    0.3030 0.06016 <.0001
Baseline    0.4947 0.04474 <.0001
Group Taxane   0.0328 0.07435 0.6591
  S-1   reference . .
Visit   3 0.1211 0.04914 0.0139
   6 0.0964 0.04925 0.0505
   12 0.1044 0.04935 0.0345
   18 0.1117 0.04956 0.0243
   24 0.0803 0.04975 0.1067
   30 0.0491 0.05033 0.3297
   36 0.0615 0.05138 0.2317
   42 0.0428 0.05324 0.4219
   48 −0.0014 0.05494 0.9793
   54 −0.0036 0.05813 0.9504
   60 reference . .
Group*visit Taxane 3 −0.0671 0.07489 0.3701
   6 −0.0600 0.07500 0.4238
   12 −0.0831 0.07527 0.2699
   18 −0.0697 0.07578 0.3579
   24 −0.0553 0.07598 0.4665
   30 −0.0228 0.07681 0.7665
   36 −0.0526 0.07774 0.4991
   42 −0.0594 0.08048 0.4603
   48 −0.0005 0.08314 0.9951
   54 0.0294 0.08627 0.7334
   60 reference . .